Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Vacca

Showing results (331-340 of 347) with videos related to

Pageof 35
Sort By:
Blood|May 27, 2016
Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUS (MM-010): a phase 3b study in refractory multiple myelomaMeletios A Dimopoulos, Antonio Palumbo, Paolo Corradini, et al.
Cells|July 26, 2024
Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC)Marco Caminati, Luisa Brussino, Matilde Carlucci, et al.
Haematologica|May 2, 2020
Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores angiogenic homeostasis and suppresses tumor progressionAntonio G Solimando, Matteo C Da Vià, Patrizia Leone, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 24, 2021
Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunityCinzia Milito, Vassilios Lougaris, Giuliana Giardino, et al.
Biologics : Targets & Therapy|November 5, 2025
Efficacy of Belimumab on Different Joint and Skin Manifestations of Systemic Lupus Erythematosus: Real-Life Data from a New Multicentric, Nationwide Italian Cohort (BeRLiSS-JS 2.0)Marisol Bracalenti, Margherita Zen, Benedetta Bianchi, et al.
Genes, Chromosomes & Cancer|December 23, 2022
circPVT1 and PVT1/AKT3 show a role in cell proliferation, apoptosis, and tumor subtype-definition in small cell lung cancerDoron Tolomeo, Debora Traversa, Santina Venuto, et al.
Lupus Science & Medicine|May 4, 2026
Efficacy of belimumab in patients with SLE and haematological manifestations: retrospective analysis from the BeRLiSS 2.0 cohortGreta Hulej, Federico Arru, Benedetta Bianchi, et al.
Journal of Clinical Immunology|August 18, 2020
The Italian Registry for Primary Immunodeficiencies (Italian Primary Immunodeficiency Network; IPINet): Twenty Years of Experience (1999-2019)Vassilios Lougaris, Andrea Pession, Manuela Baronio, et al.
The Journal of Allergy and Clinical Immunology|March 15, 2020
Long-term follow-up of 168 patients with X-linked agammaglobulinemia reveals increased morbidity and mortalityVassilios Lougaris, Annarosa Soresina, Manuela Baronio, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2021
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational StudyAlessandra Bettiol, Maria Letizia Urban, Lorenzo Dagna, et al.
Pageof 35

Showing results (331-340 of 347) with videos related to

Sort By:
Pageof 35
Blood|May 27, 2016
Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUS (MM-010): a phase 3b study in refractory multiple myelomaMeletios A Dimopoulos, Antonio Palumbo, Paolo Corradini, et al.
Cells|July 26, 2024
Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC)Marco Caminati, Luisa Brussino, Matilde Carlucci, et al.
Haematologica|May 2, 2020
Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores angiogenic homeostasis and suppresses tumor progressionAntonio G Solimando, Matteo C Da Vià, Patrizia Leone, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 24, 2021
Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunityCinzia Milito, Vassilios Lougaris, Giuliana Giardino, et al.
Biologics : Targets & Therapy|November 5, 2025
Efficacy of Belimumab on Different Joint and Skin Manifestations of Systemic Lupus Erythematosus: Real-Life Data from a New Multicentric, Nationwide Italian Cohort (BeRLiSS-JS 2.0)Marisol Bracalenti, Margherita Zen, Benedetta Bianchi, et al.
Genes, Chromosomes & Cancer|December 23, 2022
circPVT1 and PVT1/AKT3 show a role in cell proliferation, apoptosis, and tumor subtype-definition in small cell lung cancerDoron Tolomeo, Debora Traversa, Santina Venuto, et al.
Lupus Science & Medicine|May 4, 2026
Efficacy of belimumab in patients with SLE and haematological manifestations: retrospective analysis from the BeRLiSS 2.0 cohortGreta Hulej, Federico Arru, Benedetta Bianchi, et al.
Journal of Clinical Immunology|August 18, 2020
The Italian Registry for Primary Immunodeficiencies (Italian Primary Immunodeficiency Network; IPINet): Twenty Years of Experience (1999-2019)Vassilios Lougaris, Andrea Pession, Manuela Baronio, et al.
The Journal of Allergy and Clinical Immunology|March 15, 2020
Long-term follow-up of 168 patients with X-linked agammaglobulinemia reveals increased morbidity and mortalityVassilios Lougaris, Annarosa Soresina, Manuela Baronio, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2021
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational StudyAlessandra Bettiol, Maria Letizia Urban, Lorenzo Dagna, et al.
Pageof 35